The Journal of Practical Medicine >
Expression and biological function of TRP signaling pathway in hepatocellular carcinoma
Received date: 2023-08-25
Online published: 2024-04-08
In recent years， the morbidity and mortality of hepatocellular carcinoma （ HCC ） have been increasing worldwide， and the treatment strategies for HCC are still insufficient， which highlights the importance of exploring the pathogenesis and progression of HCC. Transient receptor potential （ TRP ） pathway is an important non-selective cation pathway， which is closely related to inflammatory response and sensory conduction. At present， a number of studies have shown that TRP pathway is also involved in the occurrence and development of HCC， inducing HCC invasion and migration. However， the overall potential mechanism and possible signal transduction pathways of TRP pathway in HCC remain unclear. Therefore， this article discusses the abnormal expression of TRP pathway in HCC， and reviews the key biological events of TRP pathway involved in the formation and progression of HCC， such as chronic liver inflammation-fibrosis progression， HCC cell proliferation， migration， apoptosis and HCC stem cell generation， and looks forward to its application prospect in HCC treatment. The aim is to better understand the significance of TRP pathway in HCC， help to find new therapeutic targets and effective drugs， and open up a new situation for future clinical treatment.
Zhipeng WU , Yuqin ZHANG , Minggang WANG , Rongzhen ZHANG , Dewen. MAO . Expression and biological function of TRP signaling pathway in hepatocellular carcinoma[J]. The Journal of Practical Medicine, 2024 , 40(6) : 743 -747 . DOI: 10.3969/j.issn.1006-5725.2024.06.003
| 1 | SUNG H， FERLAY J， SIEGEL R L， et al. Global Cancer Statistics 2020： GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries［J］. CA Cancer J Clin， 2021，71（3）：209-249. doi:10.3322/caac.21660 |
| 2 | VILLANUEVA A， HERNANDEZ-GEA V， LLOVET J M. Medical therapies for hepatocellular carcinoma： a critical view of the evidence［J］. Nat Rev Gastroenterol Hepatol， 2013，10（1）：34-42. doi:10.1038/nrgastro.2012.199 |
| 3 | ANWANWAN D， SINGH S K， SINGH S， et al. Challenges in liver cancer and possible treatment approaches［J］. Biochim Biophys Acta Rev Cancer， 2020，1873（1）：188314. doi:10.1016/j.bbcan.2019.188314 |
| 4 | COSENS D J， MANNING A. Abnormal electroretinogram from a Drosophila mutant［J］. Nature， 1969，224（5216）：285-287. doi:10.1038/224285a0 |
| 5 | NILIUS B， OWSIANIK G. The transient receptor potential family of ion channels［J］. Genome Biol， 2011，12（3）：218. doi:10.1186/gb-2011-12-3-218 |
| 6 | SHAPOVALOV G， RITAINE A， SKRYMA R， et al. Role of TRP ion channels in cancer and tumorigenesis［J］. Semin Immunopathol， 2016，38（3）：357-369. doi:10.1007/s00281-015-0525-1 |
| 7 | BOUSTANY C EL， BIDAUX G， ENFISSI A， et al. Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation［J］. Hepatology， 2008，47（6）：2068-2077. doi:10.1002/hep.22263 |
| 8 | STOKLOSA P， BORGSTROM A， KAPPEL S， et al. TRP channels in digestive tract cancers［J］. Int J Mol Sci， 2020，21：1877. doi:10.3390/ijms21051877 |
| 9 | MIAO X， LIU G， XU X， et al. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma［J］. Cancer Genet Cytogenet， 2008，186（1）：25-32. doi:10.1016/j.cancergencyto.2008.05.011 |
| 10 | LIU G， XIE C， SUN F， et al. Clinical significance of transient receptor potential vanilloid 2 expression in human hepatocellular carcinoma［J］. Cancer Genet Cytogenet， 2010， 197（1）：54-59. doi:10.1016/j.cancergencyto.2009.08.007 |
| 11 | KOH H H， CHOI S， PARK C K， et al. Down-regulation of TRPV6 Is Associated With Adverse Prognosis in Hepatocellular Carcinoma Treated With Curative Resection［J］. Cancer Genomics Proteomics， 2022，19（2）：259-269. doi:10.21873/cgp.20318 |
| 12 | WANG W， LIU P， ZHANG Y， et al. Expression and functions of transient receptor potential channels in liver diseases［J］. Acta Pharm Sin B， 2023，13（2）：445-459. doi:10.1016/j.apsb.2022.09.005 |
| 13 | XU J， YANG Y， XIE R， et al. The NCX1/TRPC6 Complex Mediates TGFβ-Driven Migration and Invasion of Human Hepatocellular Carcinoma Cells［J］. Cancer Res， 2018，78（10） ：2564-2576． doi:10.1158/0008-5472.can-17-2061 |
| 14 | ZHU S， YE H， XU X， et al. Involvement of TRPC7-AS1 Expression in Hepatitis B Virus-Related Hepatocellular Carcinoma［J］. J Oncol， 2021，2021：8114327. doi:10.1155/2021/8114327 |
| 15 | FANG Y， LIU G， XIE C， et al. Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway［J］. Biomed Pharmacother， 2018，101：910-919. doi:10.1016/j.biopha.2018.03.014 |
| 16 | ROEHLEN N， CROUCHET E， BAUMERT T F. Liver Fibrosis： Mechanistic Concepts and Therapeutic Perspectives［J］. Cells， 2020， 9（4）：875. doi:10.3390/cells9040875 |
| 17 | LIU Q， LEI X， CAO Z， et al. TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling［J］. Cell Biosci， 2022，12（1）：58. doi:10.1186/s13578-022-00789-4 |
| 18 | SELLI C， ERAC Y， KOSOVA B， et al. Silencing of TRPC1 regulates store-operated calcium entry and proliferation in Huh7 hepatocellular carcinoma cells［J］. Biomed Pharmacother， 2015，71：194-200. doi:10.1016/j.biopha.2015.02.024 |
| 19 | ANAND P， FILIPENKO P， HUAMAN J， et al. Selective Inhibition of Liver Cancer Cells Using Venom Peptide［J］. Mar Drugs， 2019，17（10）：587. doi:10.3390/md17100587 |
| 20 | SELLI C， PEARCE D A， SIMS A H， et al. Differential expression of storeoperated calcium-and proliferation-related genes in hepatocellular carcinoma cells following TRPC1 ion channel silencing［J］. Mol Cell Biochem， 2016， 420（1/2）：129-140． doi:10.1007/s11010-016-2776-0 |
| 21 | CHEN Y， YU Y， SUN S， et al. Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2［J］. Exp Cell Res， 2016， 349（1）：68-76. doi:10.1016/j.yexcr.2016.09.022 |
| 22 | HUANG S P， CHEN J C， WU C C， et al. Capsaicin-induced apoptosis in human hepatoma HepG2 cells［J］. Anticancer Res， 2009， 29（1）：165-174. |
| 23 | HAN L， DI C X， MAO A H， et al. Mechanism of Capsazepine inducing apoptosis of human hepatocellular carcinoma cell line HepG2［J］. Chin J Cancer Prev Trea， 2015，22（10）：764-769. |
| 24 | CHEN W T， LIN G B， LIN S H， et al. Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1［J］. PLoS One， 2018，13（1）：e0191078. doi:10.1371/journal.pone.0191078 |
| 25 | ZHANG N， BAI S H， ZHANG F H， et al. Molecular markers and mechanisms for stemness maintenance of liver cancer stem cells： a review［J］. Chin J Biotech， 2021， 37（8）： 2719-2736. |
| 26 | HU Z， CAO X， FANG Y， et al. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer［J］. Biomed Pharmacother， 2018， 105：697-706. doi:10.1016/j.biopha.2018.06.029 |
| 27 | HUANG A， YANG X R， CHUNG W Y， et al. Targeted therapy for hepatocellular carcinoma［J］. Signal Transduct Target Ther， 2020，5（1）：146. doi:10.1038/s41392-020-00264-x |
| 28 | BORT A， SPíNOLA E， RODRíGUEZ-HENCHE N， et al. Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation［J］. Oncotarget，2017，8（50）：87684-87698. doi:10.18632/oncotarget.21196 |
| 29 | THOPPIL R J， ADAPALA R K， CAPPELLI H C， et al. TRPV4 channel activation selectively inhibits tumor endothelial cell proliferation［J］. Sci Rep， 2015，5：14257. doi:10.1038/srep14257 |
| 30 | ADAPALA R K， THOPPIL R J， GHOSH K， et al. Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy［J］. Oncogene， 2016，35（3）：314-322. doi:10.1038/onc.2015.83 |
/
| 〈 |
|
〉 |